Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model

Journal of Controlled Release

Volumn 213, Issue , 2015, Pages 45-56

  Markov, Oleg V ^a   Mironova, Nadezhda L ^a   Shmendel, Elena V ^b   Serikov, Roman N ^a   Morozova, Nina G ^b   Maslov, Mikhail A ^b   Vlassov, Valentin V ^a   Zenkova, Marina A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b MIREA RUSSIAN TECHNOLOGICAL UNIVERSITY   (Russian Federation)

Author keywords

Dendritic cells; Mannose receptor; Mannosylated liposomes; Targeting

Indexed keywords

BIOMOLECULES; CELLS; CYTOLOGY; DERMATOLOGY; DNA; DYES; LIPOSOMES; MAMMALS; ONCOLOGY; RNA; TUMORS;

CYTOTOXIC T LYMPHOCYTES; DENDRITIC CELLS; DENDRITIC CELLS (DCS); LIPOSOMAL FORMULATION; MANNOSE RECEPTORS; MANNOSYLATED LIPOSOMES; TARGETING; TRANSFECTION EFFICIENCY;

NUCLEIC ACIDS;

1,2 DIOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 1,26 BIS(CHOLEST 5 EN 3BETA YLOXYCARBONYLAMINO) 7,11,16,20 TETRAAZAHEXACOSAN; CONCANAVALIN A; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; MANNOSE; MANNOSE RECEPTOR; MANNOSYLATED LIPOSOME; PLASMID DNA; RNA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LECTIN; MANNOSE BINDING LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CANCER TRANSPLANTATION; CELL KILLING; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFECTION; EX VIVO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; LUNG METASTASIS; MALE; MELANOMA; MELANOMA B16; MELANOMA CELL; METASTASIS INHIBITION; METASTATIC MELANOMA; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPLEEN CELL; STATIC ELECTRICITY; TH1 CELL; TH2 CELL; ANIMAL; C57BL MOUSE; CHEMISTRY; DENDRITIC CELL; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; MELANOMA, EXPERIMENTAL; METABOLISM; PATHOLOGY; TRANSPLANTATION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DENDRITIC CELLS; DNA; GENETIC THERAPY; GREEN FLUORESCENT PROTEINS; LECTINS, C-TYPE; LIPOSOMES; MALE; MANNOSE; MANNOSE-BINDING LECTINS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECEPTORS, CELL SURFACE; RNA, NEOPLASM; TRANSFECTION;

EID: 84936750616     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.06.028     Document Type: Article

References (69)

1. K.J. Radford, K.M. Tullett, and M.H. Lahoud Dendritic cells and cancer immunotherapy Curr. Opin. Immunol. 27 2014 26 32
2. T.A. Gardner, B.D. Elzey, and N.M. Hahn Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer Hum. Vaccin. Immunother. 8 2012 534 539
3. S. Anguille, E.L. Smits, E. Lion, V.F. van Tendeloo, and Z.N. Berneman Clinical use of dendritic cells for cancer therapy Lancet Oncol. 15 2014 e257 e267
4. E. Vacchelli, I. Vitale, A. Eggermont, W.H. Fridman, J. Fučíková, I. Cremer, J. Galon, E. Tartour, L. Zitvogel, G. Kroemer, and L. Galluzzi Trial watch: dendritic cell-based interventions for cancer therapy Oncoimmunology 2 2013 e25771
5. L.H. Butterfield Dendritic cells in cancer immunotherapy clinical trials: are we making progress? Front. Immunol. 4 2013 454
6. M.L. Salem The use of dendritic cells for peptide-based vaccination in cancer immunotherapy Methods Mol. Biol. 1139 2014 479 503
7. F. Tada, M. Abe, M. Hirooka, Y. Ikeda, Y. Hiasa, Y. Lee, N.C. Jung, W.B. Lee, H.S. Lee, Y.S. Bae, and M. Onji Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma Int. J. Oncol. 41 2012 1601 1609
8. L.E. Kandalaft, D.J. Powell Jr., C.L. Chiang, J. Tanyi, S. Kim, M. Bosch, K. Montone, R. Mick, B.L. Levine, D.A. Torigian, C.H. June, and G. Coukos Autologous lysate pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer Oncoimmunology 2 2013 e22664
9. S.K. Kim, C.H. Yun, and S.H. Han Enhanced anti-cancer activity of human dendritic cells sensitized with gamma-irradiation-induced apoptotic colon cancer cells Cancer Lett. 335 2013 278 288
10. M. Palma, L. Hansson, A. Choudhury, B. Näsman-Glaser, I. Eriksson, L. Adamson, E. Rossmann, K. Widén, R. Horváth, P. Kokhaei, S. Vertuani, H. Mellstedt, and A. Osterborg Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria Cancer Immunol. Immunother. 61 2012 865 879
11. D. Matheoud, C. Baey, L. Vimeux, A. Tempez, M. Valente, P. Louche, A. Le Bon, A. Hosmalin, and V. Feuillet Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model PLoS One 6 2011 e19104
12. L.T. Blalock, J. Landsberg, M. Messmer, J. Shi, A.D. Pardee, R. Haskell, L. Vujanovic, J.M. Kirkwood, and L.H. Butterfield Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity Oncoimmunology 1 2012 287 297
13. K. Breckpot, C. Heirman, B. Neyns, and K. Thielemans Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells J. Gene Med. 6 2004 1175 1288
14. T. Liechtenstein, N. Perez-Janices, C. Bricogne, A. Lanna, I. Dufait, C. Goyvaerts, R. Laranga, and A. Padella Immune modulation by genetic modification of dendritic cells with lentiviral vectors Virus Res. 176 2013 1 15
15. D. Benteyn, C. Heirman, A. Bonehill, K. Thielemans, and K. Breckpot mRNA-based dendritic cell vaccines Expert Rev. Vaccines 8 2014 1 16
16. F. Milano, and K.K. Krishnadath Electroporation of dendritic cells with autologous total RNA from tumor material Methods Mol. Biol. 1139 2014 87 95
17. J. Chen, X.Z. Guo, H.Y. Li, X. Liu, L.N. Ren, D. Wang, and J.J. Zhao Generation of CTL responses against pancreatic cancer in vitro using dendritic cells co-transfected with MUC4 and survivin RNA Vaccine 31 2013 4585 4590
18. J. Senesac, D. Gabrilovich, S. Pirruccello, and J.E. Talmadge Dendritic cells transfected with adenoviral vectors as vaccines Methods Mol. Biol. 1139 2014 97 118
19. L. Lin, J. Wei, Y. Chen, A. Huang, K.K. Li, and W. Zhang Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene J. Cancer Res. Clin. Oncol. 140 2014 281 289
20. R. Tao, L. Li, W. Huang, and L. Zheng Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro Hum. Gene Ther. 21 2010 98 108
21. L.J. Cruz, R.A. Rosalia, J.W. Kleinovink, F. Rueda, C.W. Löwik, and F. Ossendorp Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study J. Control. Release 192 2014 209 218
22. H. Dewitte, R. Verbeke, K. Breckpot, R.E. Vandenbroucke, C. Libert, S.C. De Smedt, and I. Lentacker Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro J. Control. Release 195 2014 138 146
23. Y. Oda, R. Suzuki, S. Otake, N. Nishiie, K. Hirata, R. Koshima, T. Nomura, N. Utoguchi, N. Kudo, K. Tachibana, and K. Maruyama Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis J. Control. Release 160 2012 362 366
24. H. Yin, R.L. Kanasty, A.A. Eltoukhy, A.J. Vegas, J.R. Dorkin, and D.G. Anderson Non-viral vectors for gene-based therapy Nat. Rev. Genet. 15 2014 541 555
25. P.L. Jiang, H.J. Lin, H.W. Wang, W.Y. Tsai, S.F. Lin, M.Y. Chien, P.H. Liang, Y.Y. Huang, and D.Z. Liu Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity Acta Biomater. 11 2015 356 367
26. B.H. Xie, J.Y. Yang, H.P. Li, B. Zhang, W. Chen, B. Zhou, B.G. Peng, L.J. Liang, and Q. He Dendritic cells transfected with hepatocellular carcinoma (HCC) total RNA induce specific immune responses against HCC in vitro and in vivo Clin. Transl. Oncol. 16 2014 753 760
27. Y.Z. Chen, G.X. Ruan, X.L. Yao, L.M. Li, Y. Hu, Y. Tabata, and J.Q. Gao Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination Pharm. Res. 30 2013 1502 1512
28. W.W. Unger, A.J. van Beelen, S.C. Bruijns, M. Joshi, C.M. Fehres, L. van Bloois, M.I. Verstege, M. Ambrosini, H. Kalay, K. Nazmi, J.G. Bolscher, E. Hooijberg, T.D. de Gruijl, G. Storm, and Y. van Kooyk Glycan-modified liposomes boost CD4 + and CD8 + T-cell responses by targeting DC-SIGN on dendritic cells J. Control. Release 160 2012 88 95
29. R. Srinivas, A. Garu, G. Moku, S.B. Agawane, and A. Chaudhuri A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups Biomaterials 33 2012 6220 6229
30. Y. Fan, P. Sahdev, L.J. Ochyl, J.J. Akerberg, and J.J. Moon Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens J. Control. Release 208 2015 121 129
31. Y. Ma, Y. Zhuang, X. Xie, C. Wang, F. Wang, D. Zhou, J. Zeng, and L. Cai The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses Nanoscale 3 2011 2307 2314
32. H. Li, L. Piao, B. Yu, B.C. Yung, W. Zhang, P.G. Wang, J.L. Lee, and R.J. Lee Delivery of calf thymus DNA to tumor by folate receptor targeted cationic liposomes Biomaterials 32 2011 6614 6620
33. P. Li, D. Liu, X. Sun, C. Liu, Y. Liu, and N. Zhang A novel cationic liposome formulation for efficient gene delivery via a pulmonary route Nanotechnology 22 2011 245104
34. S. Duarte, H. Faneca, and M.C. Lima Folate-associated lipoplexes mediate efficient gene delivery and potent antitumoral activity in vitro and in vivo Int. J. Pharm. 423 2012 365 377
35. R. Mukthavarama, S. Marepallya, M.Y. Venkataa, G.N. Vegi, R. Sistlab, and A. Chaudhuria Cationic glycolipids with cyclic and open galactose head groups for the selective targeting of genes to mouse liver Biomaterials 30 2009 2369 2384
36. H. Arima, S. Yamashita, Y. Mori, Y. Hayashi, K. Motoyama, K. Hattori, T. Takeuchi, H. Jono, Y. Ando, F. Hirayama, and K. Uekama In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes J. Control. Release 146 2010 106 117
37. A. Pathak, S.P. Vyas, and K.C. Gupta Nano-vectors for efficient liver specific gene transfer Int. J. Nanomedicine 3 2008 31 49
38. L. Martinez-Pomares The mannose receptor J. Leukoc. Biol. 92 2012 1177 1186
39. F. Perche, D. Gosset, M. Mével, M.L. Miramon, J.J. Yaouanc, C. Pichon, T. Benvegnu, P.A. Jaffrès, and P. Midoux Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes J. Drug Target. 19 2011 315 325
40. B. Carrillo-Conde, E.H. Song, A. Chavez-Santoscoy, Y. Phanse, A.E. Ramer-Tait, N.L. Pohl, M.J. Wannemuehler, B.H. Bellaire, and B. Narasimhan Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells Mol. Pharm. 8 2011 1877 1886
41. C. Pichon, and P. Midoux Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA Methods Mol. Biol. 969 2013 247 274
42. C.K. Tang, J. Lodding, G. Minigo, D.S. Pouniotis, M. Plebanski, A. Scholzen, I.F. McKenzie, G.A. Pietersz, and V. Apostolopoulos Mannan-mediated gene delivery for cancer immunotherapy Immunology 120 2007 325 335
43. D. Zhi, S. Zhang, S. Cui, Y. Zhao, Y. Wang, and D. Zhao The headgroup evolution of cationic lipids for gene delivery Bioconjug. Chem. 24 2013 487 519
44. I.A. Petukhov, M.A. Maslov, N.G. Morozova, and G.A. Serebrennikova Synthesis of polycationic lipids based on cholesterol and spermine Russ. Chem. Bull. 59 2010 260 268
45. M.A. Maslov, T.O. Kabilova, I.A. Petukhov, N.G. Morozova, G.A. Serebrennikova, V.V. Vlassov, and M.A. Zenkova Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA J. Control. Release 160 2012 182 193
46. O. Markov, N.L. Mironova, M.A. Maslov, I.A. Petukhov, N.G. Morozova, V.V. Vlassov, and M.A. Zenkova Novel cationic liposomes provided highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets J. Control. Release 160 2012 200 210
47. E.V. Shmendel, A.A. Timakova, M.A. Maslov, N.G. Morozova, and V.V. Chupin Synthesis of mannose-containing neoglycolipids as a component of targeted delivery system for transfer of nucleic acids into antigen-presenting cells Russ. Chem. Bull. 60 2012 1497 1501
48. A. Engel, S.K. Chatterjee, A. Al-arifi, D. Riemann, J. Langner, and P. Nuhn Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells Pharm. Res. 20 2003 51 57
49. O. Patutina, N. Mironova, N. Popova, V. Kaledin, V. Nikolin, V. Vlassov, and M. Zenkova The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy BMC Cancer 10 2010 204
50. A. Mauceri, S. Borocci, L. Galantini, L. Giansanti, G. Mancini, A. Martino, L. Salvati Manni, and C. Sperduto Recognition of concanavalin A by cationic glucosylated liposomes Langmuir 30 2014 11301 11306
51. C.D. Muller, and F. Schuber Neo-mannosylated liposomes: synthesis and interaction with mouse Kupffer cells and resident peritoneal macrophages Biochim. Biophys. Acta 986 1989 97 105
52. G. Entlicher, J.V. Koštíř, and J. Kocourek Studies on phytohemagglutinins. VIII. Isoelectric point and multiplicity of purified concanavalin A Biochim. Biophys. Acta 236 1971 795 797
53. C. Lonez, M. Vandenbranden, and J.M. Ruysschaert Cationic lipids activate intracellular signalling pathways Adv. Drug Deliv. Rev. 64 2012 1749 1758
54. L. Gu, L.M. Nusblat, N. Tishbi, S.C. Noble, C.M. Pinson, E. Mintzer, C.M. Roth, and K.E. Uhrich Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing J. Control. Release 184 2014 28 35
55. X. Wang, B. Yu, W. Ren, X. Mo, C. Zhou, H. He, H. Jia, L. Wang, S.T. Jacob, R.J. Lee, K. Ghoshal, and L.J. Lee Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations J. Control. Release 172 2013 690 698
56. T. Mars, M. Strazisar, K. Mis, N. Kotnik, K. Pegan, J. Lojk, Z. Grubic, and M. Pavlin Electrotransfection and lipofection show comparable efficiency for in vitro gene delivery of primary human myoblasts J. Membr. Biol. 248 2015 273 283
57. J. Rejman, G. Tavernier, N. Bavarsad, J. Demeester, and S.C. De Smedt mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers J. Control. Release 147 2010 385 391
58. W. De Haes, J. Rejman, C. Pollard, C. Merlin, M. Vekemans, E. Florence, S.C. De Smedt, J. Grooten, G. Vanham, S. De Koker, and E. Van Gulck Lipoplexes carrying mRNA encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responses Nanomedicine (Lond.) 8 2013 77 87
59. D. Chen, J. Koropatnick, N. Jiang, X. Zheng, X. Zhang, H. Wang, K. Yuan, K.S. Siu, A. Shunnar, C. Way, and W.P. Min Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma J. Immunother. 37 2014 123 134
60. Y. Lu, S. Kawakami, F. Yamashita, and M. Hashida Development of an antigen-presenting cell-targeted DNA vaccine against melanoma by mannosylated liposomes Biomaterials 28 2007 3255 3262
61. F. Perche, T. Benvegnu, M. Berchel, L. Lebegue, C. Pichon, P.A. Jaffrès, and P. Midoux Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA Nanomedicine 7 2011 445 453
62. L. Raviv, M. Jaron-Mendelson, and A. David Mannosylated polyion complexes for in vivo gene delivery into CD11c + dendritic cells Mol. Pharm. 12 2015 453 462
63. K.L. White, T. Rades, R.H. Furneaux, P.C. Tyler, and S. Hook Mannosylated liposomes as antigen delivery vehicles for targeting to dendritic cells J. Pharm. Pharmacol. 58 2006 729 737
64. Y. Hattori, S. Kawakami, Y. Lu, K. Nakamura, F. Yamashita, and M. Hashida Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration J. Gene Med. 8 2006 824 834
65. T. Keler, V. Ramakrishna, and M.W. Fanger Mannose receptor-targeted vaccines Expert Opin. Biol. Ther. 4 2004 1953 1962
66. K. Gijzen, A. Cambi, R. Torensma, and C.G. Figdor C-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates Curr. Protein Pept. Sci. 7 2006 283 294
67. C.G. Figdor, Y. van Kooyk, and G.J. Adema C-type lectin receptors on dendritic cells and Langerhans cells Nat. Rev. Immunol. 2 2002 77 84
68. H. Sheikh, H. Yarwood, A. Ashworth, and C.M. Isacke Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor J. Cell Sci. 113 2000 1021 1032
69. G. Szolnoky, Z. Bata-Csörgö, A.S. Kenderessy, M. Kiss, A. Pivarcsi, Z. Novák, K. Nagy Newman, G. Michel, T. Ruzicka, L. Maródi, A. Dobozy, and L. Kemény A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans J. Invest. Dermatol. 117 2011 205 213